BioCritica's Series A Round

BioCritica raised a round of funding on May 26, 2011.

BioCritica is a startup biotechnology company focused on continued development of Xigris, a pharmaceutical product for the treatment of severe sepsis.…

Articles about BioCritica's Series A Round: